Catalyst Wire Dossier Catalyst Wire Dossier

LumiraDx SARS-CoV-2 & Flu A/B Test

SARS-CoV-2 and influenza A/B antigen test (multiplex) · LumiraDx UK Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LumiraDx SARS-CoV-2 & Flu A/B Test, covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites

See pricing